Related Experiment Video
Updated: Jul 16, 2025

Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards
Published on: September 3, 2020
Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP Registries
Caroline Catt1,2, Johanna M Pfeil3, Daniel Barthelmes2,4
1Department of Ophthalmology, The Children's Hospital at Westmead, Westmead, New South Wales, Australia carolinecatt@hotmail.com.
Insights
A minimal dataset for retinopathy of prematurity (ROP) treatment is proposed to track outcomes. This standardized approach aims to improve patient care and enable consistent ROP research.
Area of Science:
- Ophthalmology
- Neonatology
- Clinical Data Management
Background:
- The incidence of retinopathy of prematurity (ROP) is rising, with expanding treatment options lacking comprehensive safety data.
- There is a need for standardized data collection to effectively monitor and compare ROP treatment outcomes.
Purpose of the Study:
- To define a minimal, patient-centered dataset for ROP treatment.
- To establish a feasible data set for clinical practice and collaborative outcome tracking.
- To improve patient outcomes through standardized ROP treatment research.
Main Methods:
- A multinational collaboration of clinicians and a patient representative was formed.
- Expertise in ROP and registry development guided the data set creation.
- Focus on real-world, patient-centered, minimal, and feasible parameters for routine clinical practice.
Main Results:
- Recommended data points include patient demographics, comorbidities, ROP status, and treatment details.
- Collection of ophthalmic and systemic complications, and short/long-term outcomes is advised.
- Includes data on retreatment episodes and follow-up examinations for comprehensive tracking.
Conclusions:
- The proposed parameters should be adopted in ROP registries and studies.
- Standardization will reduce variability in reports and allow meaningful comparisons.
- These parameters form the foundation for the EU-ROP and Fight Childhood Blindness! ROP Registries.
Background/Aims:
The incidence of retinopathy of prematurity (ROP) is increasing and treatment options are expanding, often without accompanying safety data. We aimed to define a minimal, patient-centred data set that is feasible to collect in clinical practice and can be used collaboratively to track and compare outcomes of ROP treatment with a view to improving patient outcomes.
Methods:
A multinational group of clinicians and a patient representative with expertise in ROP and registry development collaborated to develop a data set that focused on real-world parameters and outcomes that were patient centred, minimal and feasible to collect in routine clinical practice.
Results:
For babies receiving ROP treatment, we recommend patient demographics, systemic comorbidities, ROP status, treatment details, ophthalmic and systemic complications of treatment, ophthalmic and neurodevelopmental outcomes at initial treatment, any episodes of retreatment and follow-up examinations in the short and long-term to be collected for use in ROP studies, registries and routine clinical practice.
Conclusions:
We recommend these parameters to be used in registries and future studies of ROP treatment, to reduce the variation seen in previous reports and allow meaningful assessments and comparisons. They form the basis of the EU-ROP and the Fight Childhood Blindness! ROP Registries.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Blind Procedures
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pre-Procedural Guidelines for Assessing Blood Pressure
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

